CO2 Solutions Inc. reported earnings results for the year ended June 30, 2017. For the year, the company announced revenues of $0.05 million were recorded for the financial year ended June 30, 2017, relating to the sale of enzymes. No revenue was recorded for the same period in the prior year. Net loss for financial year June 30, 2017 decreased by $0.37 million from the prior year to $4.6 million, reflecting an increase in government grants relating to the Saint-Félicien and VCQ projects, offset partially by an increase in research and development expenses associated with these same projects.